We are live on
!
Find out more
Royalty Pharma
RPRX
RPRX
266 hedge funds and large institutions have $10.7B invested in Royalty Pharma in 2021 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 107 increasing their positions, 66 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
340% more call options, than puts
Call options by funds: $49.1M | Put options by funds: $11.2M
133% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 27
62% more repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 66
15% more funds holding
Funds holding: 232 → 266 (+34)
11% more capital invested
Capital invested by funds: $9.59B → $10.7B (+$1.1B)
0.31% more ownership
Funds ownership: 62.15% → 62.46% (+0.31%)
0% more funds holding in top 10
Funds holding in top 10: 11 → 11 (0)
Holders
266
Holders Change
+34
Holders Change %
+14.66%
% of All Funds
4.09%
Holding in Top 10
11
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.17%
New
63
Increased
107
Reduced
66
Closed
27
Calls
$49.1M
Puts
$11.2M
Net Calls
+$37.9M
Net Calls Change
+$9.57M
Top Buyers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$240M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$115M |
| 3 |
MAMU
Marathon Asset Management (UK)
London,
United Kingdom
|
+$87.1M |
| 4 |
BlackRock
New York
|
+$48.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$48.3M |
Top Sellers
| 1 |
Berkshire Hathaway
Omaha,
Nebraska
|
-$175M |
| 2 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
-$143M |
| 3 |
VCG
Vantage Consulting Group
Virginia Beach,
Virginia
|
-$127M |
| 4 |
Amundi
Paris,
France
|
-$46.4M |
| 5 |
Morgan Stanley
New York
|
-$41.7M |
